• American Salon
  • IBS
  • American Spa
  • IECSC
  • SPATEC
  • SIBEC
  • Advertise
Home
  • News
    • Industry Insiders
  • Wellness
  • Spas
    • Medical Spa
  • Fitness
  • Business
    • Education
    • Trends
  • Skincare
    • Estheticians
    • Treatments
    • Products
  • CBD
  • Video
  • IECSC
  • Magazine
  • Resources
    • Contest
    • Downloadable Guides
    • Job Openings
    • Podcast
    • Webinar
    • Partner Insights
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • News
    • Industry Insiders
  • Wellness
  • Spas
    • Medical Spa
  • Fitness
  • Business
    • Education
    • Trends
  • Skincare
    • Estheticians
    • Treatments
    • Products
  • CBD
  • Video
  • IECSC
  • Magazine
  • Resources
    • Contest
    • Downloadable Guides
    • Job Openings
    • Podcast
    • Webinar
    • Partner Insights
  • Events
  • Subscribe
  • American Salon
  • IBS
  • American Spa
  • IECSC
  • SPATEC
  • SIBEC
  • Advertise

Hugel America

Photo credit fizkesiStockGetty Images Plus
Medical Spa

Hugel Gets FDA Approval on Letybo to Treat Glabellar Lines

South Korea's market leading neurotoxin in aesthetics is set to launch in the second half of 2024.
American Spa Staff Mar 15, 2024 2:24pm
Photo credit SvetographyiStockGetty Images Plus

FDA Accepts BLA for LetibotulinumtoxinA for Injection

Oct 29, 2021 9:54am

Home
  • Connect
    • About Us
    • Advertise
    • Wellness Advisory Board
  • Join Us
    • Newsletters
    • Print Edition
    • Resources
  • Our Brands
    • American Salon
    • American Spa
    • Club Industry
  • Our Events
    • IBS New York
    • IBS Las Vegas
    • IECSC
    • SPATEC
    • Club Industry Show
    • SIBEC
    • Future of Fitness
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings